TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T08596 XX ID T08596 XX DT 20.01.2006 (created); jay. DT 12.04.2013 (updated); yre. CO Copyright (C), QIAGEN. XX FA ER-alpha XX SY ER; ER-alpha; Era; ERalpha; ER[a]; ESR; ESR1; Estr; Estra; estradiol receptor; estrogen receptor; estrogen receptor 1 (alpha); NR3A1. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G006037 Esr1. XX CL C0002; CC (rec); 2.1.1.2.1.1. XX SZ 599 AA; 66.9 kDa (cDNA) (calc.). XX SQ MTMTLHTKASGMALLHQIQGNELEPLNRPQLKMPMERALGEVYVDNSKPTVFNYPEGAAY SQ EFNAAAAAAAAASAPVYGQSGIAYGPGSEAAAFSANSLGAFPQLNSVSPSPLMLLHPPPQ SQ LSPFLHPHGQQVPYYLENEPSAYAVRDTGPPAFYRSNSDNRRQNGRERLSSSNEKGNMIM SQ ESAKETRYCAVCNDYASGYHYGVWSCEGCKAFFKRSIQGHNDYMCPATNQCTIDKNRRKS SQ CQACRLRKCYEVGMMKGGIRKDRRGGRMLKHKRQRDDLEGRNEMGASGDMRAANLWPSPL SQ VIKHTKKNSPALSLTADQMVSALLDAEPPMIYSEYDPSRPFSEASMMGLLTNLADRELVH SQ MINWAKRVPGFGDLNLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGK SQ CVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIH SQ RVLDKITDTLIHLMAKAGLTLQQQHRRLAQLLLILSHIRHMSNKGMEHLYNMKCKNVVPL SQ YDLLLEMLDAHRLHAPASRMGVPPEEPSQTQLATTSSTSAHSLQTYYIPPEAEGFPNTI XX SC translated from EMBL:M38651 XX FT 1 188 Ligand Activation Domain (AF 1) [2]. FT 1 185 PF02159; Oestrogen receptor. FT 25 505 PF00478; IMP dehydrogenase / GMP reductase domai. FT 186 257 SM00399; c4gold. FT 186 261 PS51030; NUCLEAR_REC_DBD_2. FT 187 262 PF00105; Zinc finger, C4 type (two domains). FT 189 249 DNA Binding Domain [2]. FT 255 599 LIgand Binding Domain [2]. FT 352 522 SM00430; holi. FT 355 547 PF00104; Ligand-binding domain of nuclear hormon. FT 540 552 Helix 12 [2]. XX FF Helix 12 domain is required for enhancer repression of Neu G000349 [2]; XX IN T09446 c-Jun; Mammalia. IN T19335 TIF1a-short; human, Homo sapiens. IN T04945 TIF1a; human, Homo sapiens. XX MX M07283 V$ERALPHA_Q4. MX M03547 V$ERALPHA_Q6_01. MX M03820 V$ERALPHA_Q6_02. MX M00191 V$ER_Q6. MX M00959 V$ER_Q6_02. XX BS R25135. XX DR TRANSPATH: MO000078321. DR EMBL: M38651; MMESTRU. DR UniProtKB: P19785; ESTR_MOUSE. XX RN [1]; RE0017308. RX PUBMED: 9115274. RA Thenot S., Henriquet C., Rochefort H., Cavailles V. RT Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1 RL J. Biol. Chem. 272:12062-12068 (1997). RN [2]; RE0027450. RX PUBMED: 10698518. RA Newman S. P., Bates N. P., Vernimmen D., Parker M. G., Hurst H. C. RT Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. RL Oncogene 19:490-7 (2000). RN [3]; RE0047728. RX PUBMED: 8887632. RA L'Horset F., Dauvois S., Heery D. M., Cavailles V., Parker M. G. RT RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. RL Mol. Cell. Biol. 16:6029-6036 (1996). RN [4]; RE0047810. RX PUBMED: 14701856. RA Debril M. B., Gelman L., Fayard E., Annicotte J. S., Rocchi S., Auwerx J. RT Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit. RL J. Biol. Chem. 279:16677-16686 (2004). RN [5]; RE0048348. RX PUBMED: 9892017. RA Alen P., Claessens F., Schoenmakers E., Swinnen J. V., Verhoeven G., Rombauts W., Peeters B. RT Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. RL Mol. Endocrinol. 13:117-128 (1999). XX //